Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong · Delayed Price · Currency is HKD 19.05
-0.51 (-2.61%)
Jul 9, 2026, 4:08 PM HKT
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 6.21 billion as of July 9, 2026.
Market Cap
6.21B
Enterprise Value
5.18B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.05
Market Cap Chart
Since December 10, 2025, HKG:2659's market cap has decreased from 20.54B to 6.21B, a decrease of -69.76%. That is a compound annual growth rate of -87.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.21B | -75.44% |
| Dec 31, 2025 | 25.28B | 23.10% |
| Dec 10, 2025 | 20.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Ribo Life Science | 8.84B |
| CStone Pharmaceuticals | 8.73B |
| Abbisko Cayman | 8.30B |
| Lepu Biopharma | 8.21B |
| LongBio Pharma (Suzhou) | 7.97B |
| Shanghai Haohai Biological Technology | 7.51B |
| Alphamab Oncology | 7.46B |
| CK Life Sciences Int'l., (Holdings) | 5.77B |